Research on Eczema in Unani Medicine

A Comparative study on the efficacy of Matbookh Haleela with local application of Mazo and Sirka versus Marham-e-Asfedaj in Nar-e-Farsi Muzmin

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053446

Enrollment

Registered

2023-06-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L259- Unspecified contact dermatitis, unspecified cause

Interventions

Intervention1: Mazo with Sirka and Matbookh-e-Haleela: Group A will be given Mazo with Sirka 10gms twice a day for local application for 30 days and Matbookh Haleela 15gms once a day to drink empty s

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with age between 18-60 years 2.Both genders. 3.Diagnosed cases of Eczema as per Hannifin & Rajika Criteria. 4.Patients who will give consent and able to do follow up

Exclusion criteria

Exclusion criteria: 1.Patients below 18 and above 60 years of age. 2.Mellitus Pregnant and lactating women. 3.Patients having local wound and other skin diseases. 4.Patients suffering from systemic illnesses like Diabetes, Malignancy Patients of Acute Eczema of 2 weeks with vesicles and oozing, Seborrheic Dermatitis, Stasis Dermatitis, Psoriasis and Exfoliative Dermatitis

Design outcomes

Primary

Measure	Time frame
Primary Outcome Decrease In EASITimepoint: 30days	—

Secondary

Measure	Time frame
Secondary Outcome- Decrease in POEM and PhotographyTimepoint: 30days	—

Countries

India

Contacts

Public ContactDr Mohd Aleemuddin Quamri

National Institute of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026